Newly activated UI Cancer Center clinical trial

Newly activated UI Cancer Center clinical trial

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on ClinicalTrials.gov. For more information or questions about a study, please email cancertrials@uic.edu or call 312-355-5112.

S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Sponsor: Southwest Oncology Group
Principle Investigator: Rozina Chowdhery, MD

Leave a reply

Your email address will not be published. Required fields are marked *